Ann: Teva Launches Generic Version of Axiron in United States, page-5

  1. 84 Posts.
    lightbulb Created with Sketch. 31
    Is that allowed - To charge the impairment based on data results released on 6th July 2017, when the financial reports are dates ending on 30 Jun 2017. I would think that the impairment would be charged to the next FY results, because at the time of 30th Jun, they wouldn't have known the impact and couldn't calculate the impairment. Not that it matters, but seems to be softening the blow of next year's results.

    Genuine curious question.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.9¢
Change
0.000(0.00%)
Mkt cap ! $7.747M
Open High Low Value Volume
1.9¢ 1.9¢ 1.9¢ $5.562K 292.7K

Buyers (Bids)

No. Vol. Price($)
4 381825 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 60000 2
View Market Depth
Last trade - 15.04pm 20/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.